LOL. I find it humorous to attack management after delivering the first ever trial to show overall survival benefits for both rGBM and nGBM, including 5 year data. They did this while nefarious forces were trying to bankrupt them throughout the entire process. Without our management team this company would have folded long ago. Kudos to management for their perseverance and completing this groundbreaking trial. Up next is RA approvals. Pointing fingers at management is a standard short practice.
It must be a partnership with this management team sailing into the sunset with bags full of cash. For the sake of cancer patients they should not oversee any other trials or manufacturing processes. Left to her own devices, LP will create infinite start ups to strip value from NWBO while enriching Toucan.
This platform will change how cancer is treated… eventually. Let’s get this show on the road.